Journal for ImmunoTherapy of Cancer : Impact Factor & More
eISSN: 2051-1426pISSN: 2051-1426
Open AccessShare this on:
Key Metrics
CiteScore 
14.3
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q1Oncology
SNIP
2.23
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2885 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Society for Immunotherapy of Cancer |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal for ImmunoTherapy of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal for ImmunoTherapy of Cancer
Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes.
- 16 Apr 2026
- Journal for immunotherapy of cancer
Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Comprehensive molecular characterization of cfDNA as predictive and monitoring biomarkers in advanced gastric cancer receiving immunotherapy.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Ernest C Borden (1939-2026): in memoriam for a life of caring, researching, leading, teaching and serving.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Toward organ preservation in thoracic malignancies: why interpretable multimodal radiopathomics matters in the neoadjuvant immunotherapy era.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes.
- 16 Apr 2026
- Journal for immunotherapy of cancer
Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Comprehensive molecular characterization of cfDNA as predictive and monitoring biomarkers in advanced gastric cancer receiving immunotherapy.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Ernest C Borden (1939-2026): in memoriam for a life of caring, researching, leading, teaching and serving.
- 15 Apr 2026
- Journal for immunotherapy of cancer
Toward organ preservation in thoracic malignancies: why interpretable multimodal radiopathomics matters in the neoadjuvant immunotherapy era.
- 15 Apr 2026
- Journal for immunotherapy of cancer
FAQs on Journal for ImmunoTherapy of Cancer
How long has Journal for ImmunoTherapy of Cancer been actively publishing? 
What is the publishing frequency of Journal for ImmunoTherapy of Cancer?
How many articles did Journal for ImmunoTherapy of Cancer publish last year?
What is the eISSN & pISSN for Journal for ImmunoTherapy of Cancer?
What is Citescore for Journal for ImmunoTherapy of Cancer?
What is SNIP score for Journal for ImmunoTherapy of Cancer?
What is the SJR for Journal for ImmunoTherapy of Cancer?
Who is the publisher of Journal for ImmunoTherapy of Cancer?
